Following Outcomes Remotely Within Addiction Recovery Domains
FORWARD
CTN-0126 Following Outcomes Remotely Within Addiction Recovery Domains
2 other identifiers
observational
1,600
1 country
1
Brief Summary
The aim of this study is to describe outcome of people with opioid use disorder over the long-term by collecting monthly and yearly data on their recovery. Adults with opioid use disorder who participate will complete surveys monthly online and once per year by phone about their substance use, mental health, treatment involvement and functioning. The goal of this study is to better understand how people with opioid use disorder recover over time to improve intervention for this group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedStudy Start
First participant enrolled
September 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
May 13, 2025
May 1, 2025
2.8 years
August 14, 2023
May 9, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Opioid Use
Count of months of opioid use.
12 months
Engagement in Treatment
Count of months engaged in treatment for opioid use disorder
12 months
Eligibility Criteria
Adults with opioid use disorder who have previously participated in one of two applicable opioid use disorder clinical trials in the NIDA Clinical Trials Network.
You may qualify if:
- Be an enrolled participant in one of two applicable clinical trials and be no longer than 24 months after the final expected assessment for that trial.
- Be willing and able to provide locator information for survey distribution (mobile number and/or email address).
- Be willing to allow the linkage of prior clinical trial study data to the current study record.
You may not qualify if:
- Unable to understand or communicate to complete consent or study assessments.
- Are currently in jail, prison or other overnight facility as required by court of law or have pending legal action that could prevent participation in study activities.
- Other factors that would cause harm or increased risk to the participant or close contacts or preclude the participant's full adherence with or completion of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mclean Hospitallead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
McLean Hospital
Belmont, Massachusetts, 02478, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 14, 2023
First Posted
August 21, 2023
Study Start
September 2, 2023
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
May 13, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share